What is Alto Neuroscience's AOCI?

Alto Neuroscience (ANRO) reported AOCI of $13K in Q1 2026.

How has Alto Neuroscience's AOCI changed year-over-year?

Alto Neuroscience's AOCI decreased by 7.1% year-over-year, from $14K to $13K.

What is the long-term trend for Alto Neuroscience's AOCI?

Over 2 years (2023 to 2025), Alto Neuroscience's AOCI has grown at a -47.2% compound annual growth rate (CAGR), from -$79K to $22K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Alto Neuroscience ANRO AOCI

AOCI at other companies

Xenon PharmaceuticalsXENE

-$1.21M-44.9%

Acadia PharmaceuticalsACAD

-$563K-229%

Rapport Therapeutics, Inc.RAPP

-$505K-432%

Praxis Precision Medicines, Inc.PRAX

-$1.59M-342%

MeiraGTx Holdings plcMGTX

$2.58M+151%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$208K—

Other financials

Income statement

See full

Operating income-$27.1M-73.1%

Net income-$26.2M-73.0%

EPS (diluted)-$0.80-42.9%

Balance sheet

See full

Cash & equivalents$264.3M+63.9%

Total debt$20.9M-17.2%

Total equity$243.4M+75.0%

Total assets$276.3M+60.7%

Cash flow

See full

Operating cash flow-$27.1M-63.6%

CapEx$556.0K+2,217%

Free cash flow-$27.6M-66.7%

Valuation

See full

Market cap$874.19M+1,335%

Enterprise value$630.81M-940%

Returns & leverage

See full

Return on equity-38.9%+0.9pp

Debt / equity0.1×-0.1×

Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alto Neuroscience's AOCI?: Alto Neuroscience (ANRO) reported AOCI of $13K in Q1 2026.
How has Alto Neuroscience's AOCI changed year-over-year?: Alto Neuroscience's AOCI decreased by 7.1% year-over-year, from $14K to $13K.
What is the long-term trend for Alto Neuroscience's AOCI?: Over 2 years (2023 to 2025), Alto Neuroscience's AOCI has grown at a -47.2% compound annual growth rate (CAGR), from -$79K to $22K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.